Location History:
- Nuembrecht, DE (2011 - 2019)
- Numbrecht, DE (2020 - 2024)
Company Filing History:
Years Active: 2011-2024
Title: Holger Goebel: Innovator in Radiation Treatment Technology
Introduction
Holger Goebel is a notable inventor based in Nuembrecht, Germany. He has made significant contributions to the field of radiation therapy, particularly in optimizing treatment methods for proton and ion-beam therapies. With a total of 6 patents to his name, Goebel's work has the potential to enhance the efficiency and effectiveness of cancer treatments.
Latest Patents
One of Holger Goebel's latest patents focuses on a time-optimized radiation treatment method. This innovative approach involves receiving treatment information related to a proton or ion-beam therapy plan intended to irradiate target tissue. The method also includes gathering machine-limitation information regarding the capabilities of the machines used in the therapy. By determining a time-optimized beam current based on this information, the method aims to minimize the time required to deliver a necessary quantity of monitor units to specific areas of the target tissue. This advancement is crucial for improving patient outcomes and streamlining treatment processes.
Career Highlights
Throughout his career, Holger Goebel has worked with prominent organizations in the medical technology sector. Notably, he has been associated with Varian Medical Systems Particle Therapy GmbH and Varian Medical Systems Particle Therapy GmbH & Co. KG. His experience in these companies has allowed him to develop and refine his innovative ideas in radiation therapy.
Collaborations
Holger Goebel has collaborated with talented professionals in his field, including Isabel Huth and Jan Timmer. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Holger Goebel's contributions to radiation treatment technology exemplify the impact of innovation in healthcare. His patents and career achievements reflect a commitment to improving cancer treatment methodologies.